Trial reportPloS one2025
Effect of exercise on Fibroblast Growth Factor 21 levels in healthy males and females.
Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Thermogenic adipose tissue in older adults with obesity: a narrative review of mechanisms, brown fat resistance, and the translational relevance of exercise and nutrition.Frontiers in nutrition · 2026Review
- Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross-Sectional Study.Biomolecules · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibroblast growth factor 21 (FGF21) is a metabolic regulator that may increase in circulation following exercise. This study was undertaken to determine if changes to FGF21 post-exercise are dependent on biological sex and exercise modality. Secondary analyses were conducted to determine if the post-exercise rise in FGF21 was associated with upstream signaling factors (glucagon, epinephrine, glucose) and excess post-exercise oxygen consumption (EPOC) response. Following a randomized crossover design, male and female participants completed two, thirty minute exercise protocols - during the steady state (SS) protocol, participants cycled at 70% of VO2peak and during the sprint interval exercise (IE) protocol participants completed six, thirty second "all out" sprints against 7.5% of body weight with four and half minutes of active recovery between sprints. Blood samples were taken at baseline, immediately post-exercise (IPE), and 1-hour post-exercise. Oxygen consumption was monitored continuously throughout the trials. In males, FGF21 levels were increased at 1-hour post-exercise with no difference between conditions; in females, FGF21 levels were unchanged as a result of exercise. Comparison of the post-exercise FGF21 incremental area under the curve revealed that in the SS condition males had a greater FGF21 response than females and that within males the SS condition had a greater response than the IE condition. Exercise significantly increased FGF21 levels in males, but not in females. In males, FGF21 levels were greater in the SS condition than in the IE condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.